Viewing Study NCT01456351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-02-11 @ 6:57 AM
Study NCT ID: NCT01456351
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2011-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab
Sponsor: University of Giessen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
None Mantle Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Event free survival View
None Remission rates View
None Toxicity View
None Overall survival View
None Efficiency costs View
None Recurrent low grade View